Skip to main content
Journal cover image

Statins and age-related macular degeneration: time for a randomized controlled trial?

Publication ,  Journal Article
Wong, TY; Rogers, SL
Published in: Am J Ophthalmol
July 2007

Duke Scholars

Published In

Am J Ophthalmol

DOI

ISSN

0002-9394

Publication Date

July 2007

Volume

144

Issue

1

Start / End Page

117 / 119

Location

United States

Related Subject Headings

  • Wisconsin
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Ophthalmology & Optometry
  • Macular Degeneration
  • Incidence
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Drug Utilization
  • Disease Progression
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wong, T. Y., & Rogers, S. L. (2007). Statins and age-related macular degeneration: time for a randomized controlled trial? Am J Ophthalmol, 144(1), 117–119. https://doi.org/10.1016/j.ajo.2007.04.018
Wong, Tien Y., and Sophie L. Rogers. “Statins and age-related macular degeneration: time for a randomized controlled trial?Am J Ophthalmol 144, no. 1 (July 2007): 117–19. https://doi.org/10.1016/j.ajo.2007.04.018.
Wong TY, Rogers SL. Statins and age-related macular degeneration: time for a randomized controlled trial? Am J Ophthalmol. 2007 Jul;144(1):117–9.
Wong, Tien Y., and Sophie L. Rogers. “Statins and age-related macular degeneration: time for a randomized controlled trial?Am J Ophthalmol, vol. 144, no. 1, July 2007, pp. 117–19. Pubmed, doi:10.1016/j.ajo.2007.04.018.
Wong TY, Rogers SL. Statins and age-related macular degeneration: time for a randomized controlled trial? Am J Ophthalmol. 2007 Jul;144(1):117–119.
Journal cover image

Published In

Am J Ophthalmol

DOI

ISSN

0002-9394

Publication Date

July 2007

Volume

144

Issue

1

Start / End Page

117 / 119

Location

United States

Related Subject Headings

  • Wisconsin
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Ophthalmology & Optometry
  • Macular Degeneration
  • Incidence
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Drug Utilization
  • Disease Progression